Original article
Use of antibiotic-impregnated cement during hip and knee arthroplasty in the United States

https://doi.org/10.1016/S0883-5403(05)80148-2Get rights and content

Abstract

A survey of practicing orthopaedists regarding their use of antibiotic(s) in bone—cement (ABC) was carried out. The initial sampling of 2,139 orthopaedists spanned the continental United States. Responses that passed fail—edit criteria were obtained from 1,015 physicians. Clinical practice patterns are highly variable. Adult reconstructive orthopaedic practitioners' belief in antibiotic(s) in bone—cement for the treatment of patients with previous sepsis is favorable. This opinion can be supported at the guideline level. Guidelines suggesting that liquid antibiotics should not be used as additions to polymethyl methacrylate are also supportable. The need for careful scientific inquiry and cost-effectiveness evaluation of the benefits and risks relating to the use of antibiotic additions to polymethyl methacrylate cement in joint arthroplasty exists. On the basis of such inquiry, educational dissemination to reduce practice variation would be indicated.

References (26)

  • GarvinKL et al.

    Role of gentamicin-impregnated cement in total joint arthroplasty

    Orthop Clin North Am

    (1988)
  • CherneyDL et al.

    Total hip replacement in the previously septic hip

    J Bone Joint Surg

    (1983)
  • InsallJN et al.

    Two-stage reimplantation for the salvage of infected total knee arthroplasty

    J Bone Joint Surg

    (1983)
  • JonesDR et al.

    Delayed reconstruction for the infected hip implant: a prospective study

    Orthop Trans

    (1983)
  • JupiterJB et al.

    Total hip arthroplasty in the treatment of adult hips with current or quiescent sepsis

    J Bone Joint Surg

    (1981)
  • LynchM et al.

    Deep infection in Charnley low-friction arthroplasty

    J Bone Joint Surg

    (1987)
  • BuchholzHW et al.

    Management of deep infection of total hip replacement

    J Bone Joint Surg

    (1981)
  • BuchholzHW et al.

    Uber die Depotwirkung einiger antibiotika bei Vermischung mi dem Kunstharz Palacos

    Chirurgie

    (1970)
  • CallaghanJJ et al.

    Results of revision for mechanical failure after cemented total hip replacement: 1979 to 1982

    J Bone Joint Surg

    (1985)
  • FitzgeraldRH et al.

    Deep wound sepsis following total hip arthroplasty

    J Bone Joint Surg

    (1977)
  • MarksKE et al.

    Antibiotic-impregnated acrylic bone cement

    J Bone Joint Surg

    (1976)
  • WahligH et al.

    The release of gentamicin from polymethyl methacrylate beads: an experimental and pharmacokinetic study

    J Bone Joint Surg

    (1978)
  • WahligH et al.

    Pharmacokinetic study of gentamicin-loaded cement in total hip replacements: comparative effects of varying dosage

    J Bone Joint Surg

    (1984)
  • Cited by (87)

    • When and How Should I Use Antibiotic Cement in Primary and Revision Joint Arthroplasty?

      2022, Journal of Arthroplasty
      Citation Excerpt :

      Consequently, it is critical as a surgeon to understand the elution properties of high-dose ALBC to safely and effectively treat PJIs. High-dose ALBC has become the gold standard for the treatment of chronic PJIs, and multiple studies have shown ALBC to be effective in eradicating infections [3,9–11]. However, the effectiveness of low-dose ALBC (<2 g per 40-g batch) as prophylaxis is more controversial.

    • Success rates, characteristics, and costs of articulating antibiotic spacers for total knee periprosthetic joint infection

      2017, Knee
      Citation Excerpt :

      There are currently few Food and Drug Administration (FDA) approved premixed cements available in the United States, and the doses (0.5–1.0 g of aminoglycoside antibiotic per 40 g of cement) of antibiotic in these cements are limited [22]. This has led surgeons to create their own antibiotic cement mixtures intraoperatively, producing a variable final product [1,23]. Commercially available prefabricated spacers, intraoperative spacer molds, and a variety of different intraoperatively created static and articulating antibiotic spacer constructs have been described in the literature.

    • Biocompatible Coating

      2014, Comprehensive Materials Processing
    View all citing articles on Scopus

    Supported in part by EM Industries, Hawthorne, NY.

    View full text